Cardiovascular events and intensity of treatment in polycythemia vera R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ... New England Journal of Medicine 368 (1), 22-33, 2013 | 936 | 2013 |
Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis U Testa, R Riccioni, S Militi, E Coccia, E Stellacci, P Samoggia, ... Blood, The Journal of the American Society of Hematology 100 (8), 2980-2988, 2002 | 366 | 2002 |
Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients G Visani, C Finelli, U Castelli, MC Petti, P Ricci, N Vianelli, L Gianni, ... British journal of haematology 75 (1), 4-9, 1990 | 251 | 1990 |
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance G Avvisati, F Lo-Coco, FP Paoloni, MC Petti, D Diverio, M Vignetti, ... Blood, The Journal of the American Society of Hematology 117 (18), 4716-4725, 2011 | 219 | 2011 |
Fludarabine, cytarabine, and G‐CSF (FLAG) for the treatment of poor risk acute myeloid leukemia M Montillo, S Mirto, MC Petti, R Latagliata, S Magrin, A Pinto, V Zagonel, ... American journal of hematology 58 (2), 105-109, 1998 | 190 | 1998 |
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 … EN Oliva, C Alati, V Santini, A Poloni, A Molteni, P Niscola, F Salvi, ... The Lancet Haematology 4 (3), e127-e136, 2017 | 180 | 2017 |
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic … MT Voso, S Fenu, R Latagliata, F Buccisano, A Piciocchi, MA Aloe-Spiriti, ... J Clin Oncol 31 (21), 2671-2677, 2013 | 174 | 2013 |
Negative prognostic value of glutathione S-transferase(GSTM1 and GSTT1) deletions in adult acute myeloid leukemia MT Voso, F D'Alo', R Putzulu, L Mele, A Scardocci, P Chiusolo, ... Blood, The Journal of the American Society of Hematology 100 (8), 2703-2707, 2002 | 163 | 2002 |
Therapy-related myelodysplastic syndrome–acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem R Latagliata, MC Petti, S Fenu, M Mancini, MAA Spiriti, M Breccia, ... Blood, The Journal of the American Society of Hematology 99 (3), 822-824, 2002 | 148 | 2002 |
A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia F Mandelli, MC Petti, A Ardia, N Di Pietro, F Di Raimondo, F Ganzina, ... European Journal of Cancer and Clinical Oncology 27 (6), 750-755, 1991 | 137 | 1991 |
CD 7 positive acute myeloid leukaemia: a subtype associated with cell immaturity FL Coco, GD Rossi, D Pasqualetti, M Lopez, D Diverio, R Latagliata, ... British Journal of Haematology 73 (4), 480-485, 1989 | 136 | 1989 |
Identification of risk factors in atypical chronic myeloid leukemia M Breccia, F Biondo, R Latagliata, I Carmosino, F Mandelli, G Alimena Haematologica 91 (11), 1566-1568, 2006 | 131 | 2006 |
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features M Breccia, G Avvisati, R Latagliata, I Carmosino, A Guarini, MS De Propris, ... Leukemia 21 (1), 79-83, 2007 | 130 | 2007 |
Life after ruxolitinib: reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis F Palandri, M Breccia, M Bonifacio, N Polverelli, EM Elli, G Benevolo, ... Cancer 126 (6), 1243-1252, 2020 | 124 | 2020 |
Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome MAA Spiriti, R Latagliata, P Niscola, A Cortelezzi, M Francesconi, ... Annals of Hematology 84, 167-176, 2005 | 116 | 2005 |
Melphalan treatment in patients with myelofibrosis with myeloid metaplasia MC Petti, R Latagliata, T Spadea, A Spadea, E Montefusco, ... British journal of haematology 116 (3), 576-581, 2002 | 115 | 2002 |
Survival of elderly patients with acute myeloid leukemia A Pulsoni, L Pagano, R Latagliata, M Casini, R Cerri, M Crugnola, ... haematologica 89 (3), 296-302, 2004 | 109 | 2004 |
Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic … M Breccia, R Latagliata, F Stagno, L Luciano, A Gozzini, F Castagnetti, ... Haematologica 96 (10), 1457, 2011 | 108 | 2011 |
Pilot study of 5-aza-2'-deoxycytidine (Decitabine) in the treatment of poor prognosis acute myelogenous leukemia patients: preliminary results. MC Petti, F Mandelli, V Zagonel, C De Gregoris, MC Merola, R Latagliata, ... Leukemia 7, 36-41, 1993 | 108 | 1993 |
Differences among young adults, adults and elderly chronic myeloid leukemia patients F Castagnetti, G Gugliotta, M Baccarani, M Breccia, G Specchia, L Levato, ... Annals of Oncology 26 (1), 185-192, 2015 | 102 | 2015 |